UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model

Frontiers in immunology, 2018-03, Vol.9, p.416-416

2018

Volltextzugriff (PDF)

G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma

Nature communications, 2023-02, Vol.14 (1), p.563-563, Article 563

2023

Volltextzugriff (PDF)

Challenges of CAR- and TCR-T cell-based therapy for chronic infections

The Journal of experimental medicine, 2020-05, Vol.217 (5)

2020

Volltextzugriff (PDF)

HBV as a target for CAR or TCR-T cell therapy

Current opinion in immunology, 2020-10, Vol.66, p.35-41

2020

Volltextzugriff (PDF)

Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire

Journal of Virology, 2008-11, Vol.82 (22), p.10986-10997

2008

Volltextzugriff (PDF)

Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective

Journal of gastroenterology and hepatology, 2008-06, Vol.23 (6), p.833-843

2008

Volltextzugriff (PDF)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

Hepatology communications, 2022-04, Vol.6 (4), p.841-854

2022

Volltextzugriff (PDF)

272 Use of LioCyx-M, autologous hepatitis B virus (HBV)-Specific T cell receptor (TCR) T-cells, in advanced HBV-related hepatocellular carcinoma (HCC)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A166-A167

2020

Volltextzugriff (PDF)

Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model

Frontiers in immunology, 2018-07, Vol.9, p.1719-1719

2018

Volltextzugriff (PDF)

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity

The Journal of experimental medicine, 2022-10, Vol.219 (10)

2022

Volltextzugriff (PDF)

A Dynamic Immune Response Shapes COVID-19 Progression

Cell host & microbe, 2020-06, Vol.27 (6), p.879-882.e2

2020

Volltextzugriff (PDF)

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future

Diseases, 2016-02, Vol.4 (1), p.10

2016

Volltextzugriff (PDF)

T-cell therapy for chronic viral hepatitis

Cytotherapy (Oxford, England), 2017-11, Vol.19 (11), p.1317-1324

2017

Volltextzugriff (PDF)

Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1862-1876.e9

2019

Volltextzugriff (PDF)

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

Hepatology international, 2021-12, Vol.15 (6), p.1402-1412

2021

Volltextzugriff (PDF)

Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy

Cellular & molecular immunology, 2023-11, Vol.20 (11), p.1300-1312

2023

Volltextzugriff (PDF)

Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood

Immunotherapy advances, 2023-01, Vol.3 (1), p.ltad015-ltad015

2023

Volltextzugriff (PDF)

Abstract 1781: G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1781-1781

2023

Volltextzugriff (PDF)

Murine Models and Human Studies of Pathogenesis of Chronic Hepatitis B

Viral Hepatitis, 2013, p.176-187

2013

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)
Buchkapitel
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model

G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma

Challenges of CAR- and TCR-T cell-based therapy for chronic infections

HBV as a target for CAR or TCR-T cell therapy

Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire

Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

272 Use of LioCyx-M, autologous hepatitis B virus (HBV)-Specific T cell receptor (TCR) T-cells, in advanced HBV-related hepatocellular carcinoma (HCC)

Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity

A Dynamic Immune Response Shapes COVID-19 Progression

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future

T-cell therapy for chronic viral hepatitis

Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy

Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood

Abstract 1781: G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma

Murine Models and Human Studies of Pathogenesis of Chronic Hepatitis B

Differential Effects of the Second SARS-CoV-2 mRNA Vaccine Dose on T Cell Immunity in Naïve and COVID-19 Recovered Individuals

Suchergebnisse filtern